A 25-gene classifier predicts overall survival in resectable pancreatic cancer

BACKGROUND: Pancreatic carcinoma is one of the most lethal human cancers. In patients with resectable tumors, surgery followed by adjuvant chemotherapy is the only curative treatment. However, the 5-year survival is 20%. Because of a strong metastatic propensity, neoadjuvant chemotherapy is being te...

Descripción completa

Detalles Bibliográficos
Autores principales: Birnbaum, David J., Finetti, Pascal, Lopresti, Alexia, Gilabert, Marine, Poizat, Flora, Raoul, Jean-Luc, Delpero, Jean-Robert, Moutardier, Vincent, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606023/
https://www.ncbi.nlm.nih.gov/pubmed/28927421
http://dx.doi.org/10.1186/s12916-017-0936-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606023/
https://www.ncbi.nlm.nih.gov/pubmed/28927421
http://dx.doi.org/10.1186/s12916-017-0936-z

Ejemplares similares